[内分泌科2型糖尿病患者心血管疾病的实用防治]
[Practical prevention and treatment of cardiovascular diseases in patients with diabetes mellitus type 2 in an endocrinological department].
作者信息
Daurbekova L V, Orlov V A, Giliarevskiĭ S R, Abirova E S, Murzabekova L I
出版信息
Ter Arkh. 2004;76(12):32-6.
AIM
To analyse retrospectively quality of medical correction of modified risk factors (RF) and treatment of cardiovascular diseases (CVD) in patients with diabetes mellitus type (DM) 2 admitted to specialized endocrinological departments.
MATERIAL AND METHODS
Analysis of medication policy of CVD RF was made retrospectively for 250 patients treated in endocrinological departments of Moscow hospital in 2003.
RESULTS
Arterial hypertension, coronary heart disease were diagnosed in 93.2 and 87.2% examinees. History of myocardial infarction and brain stroke was in 8.4 and 6% patients. Statins were prescribed in 2.4% cases. Examination for dyslipidemia was not satisfactory. ACE inhibitors were prescribed in 71.2% patients. Aspirin was prescribed (18%) primarily by the cardiologist.
CONCLUSION
Quality of medical prophylaxis of CVD RF in DM type 2 patients in the departments does not satisfy modern clinical recommendations.
目的
回顾性分析入住专业内分泌科的2型糖尿病（DM）患者改良危险因素（RF）的医学纠正质量及心血管疾病（CVD）的治疗情况。
材料与方法
对2003年在莫斯科医院内分泌科接受治疗的250例患者的心血管疾病RF药物治疗策略进行回顾性分析。
结果
93.2%和87.2%的受检者被诊断为动脉高血压和冠心病。8.4%和6%的患者有心肌梗死和脑卒中病史。2.4%的病例使用了他汀类药物。血脂异常检查结果不理想。71.2%的患者使用了血管紧张素转换酶抑制剂。阿司匹林（18%）主要由心脏病专家开具。
结论
各科室2型糖尿病患者心血管疾病RF的医学预防质量未达到现代临床建议。
Zotero 插件